Berkeley California based Xalud Therapeutics is raising $25,150,000.00 in New Equity Investment.
Berkeley, CA – According to filings with the U.S. Securities and Exchange Commission, Xalud Therapeutics is raising $25,150,000.00 in new funding. Sources indicate as part of senior management Executive Chairman, Stephen Collins played a key…